(Q35079976)

6 August 2017

1 reference

title

Normocalcemic primary hyperparathyroidism. (English)

1 reference

6 August 2017

1 reference

1

John P Bilezikian

1 reference

6 August 2017

Shonni J Silverberg

2

1 reference

6 August 2017

publication date

1 March 2010

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

6 August 2017

published in

1 reference

6 August 2017

volume

54

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

106-109

1 reference

Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3127400

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3127400

The Vitamin D requirement in health and disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3127400

Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3127400

Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3127400

Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3127400

Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3127400

Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3127400

Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3127400

Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3127400

Characterization of normocalcemic primary hyperparathyroidism

27 September 2018

1 reference

12 December 2020

A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples

1 reference

12 December 2020

Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism

1 reference

12 December 2020

“Incipient” Primary Hyperparathyroidism: A “Forme Fruste” of an Old Disease

1 reference

12 December 2020

Normocalcemic primary hyperparathyroidism

1 reference

12 December 2020

Consensus development conference statement

1 reference

12 December 2020

Normocalcemic hyperparathyroidism in patients with osteoporosis

1 reference

12 December 2020

10.1590/S0004-27302010000200004

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference